Glucosylceramidase (GBA), leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2), and α-Syn mutations have been associated with PD-MCI and PDD (Aarsland et al., 2017). The gene discussed is LRRK2; the disease is Parkinson disease.